ARTICLE | Company News
Xenova other research news
October 16, 1995 7:00 AM UTC
XNVAY (Slough, U.K.) received a grant for up to $696,000 from the U.K. Department of Trade and Industry to fund development through Phase I trials of XNVAY's anti-cancer compound to address multi-drug...